Tolga Tanguler, EVP, Chief Commercial Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 6,948 shares at $449.54 ($3.1M) on 2025-08-29, disclosed to the SEC on 2025-09-02.
Scheduled sale ($3.1M) by EVP, Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $445.53 | 195 | $87K | 2.8% |
| 2 | $445.53 | 195 | $87K | 2.8% |
| 3 | $446.98 | 899 | $402K | 12.9% |
| 4 | $446.98 | 899 | $402K | 12.9% |
| 5 | $448.05 | 1,289 | $578K | 18.5% |
| 6 | $448.05 | 1,289 |
| $578K |
| 18.5% |
| 7 | $449.54 | 681 | $306K | 9.8% |
| 8 | $449.54 | 681 | $306K | 9.8% |
| 9 | $451.52 | 266 | $120K | 3.9% |
| 10 | $451.52 | 266 | $120K | 3.9% |
| 11 | $452.49 | 144 | $65K | 2.1% |
| 12 | $452.49 | 144 | $65K | 2.1% |
| Total | $448.37 avg | 6,948 | $3.1M | 100% |
| Filing → |
| ALNY | SELL | 2026-02-17 | $607K | — | Filing → |
| ALNY | SELL | 2026-01-14 | $548K | — | Filing → |
| ALNY | SELL | 2025-10-03 | $1.1M | — | Filing → |